Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which of the following drugs undergoes Hoffmann elimination?

Atracurium. **Explanation:** **Atracurium** is the correct answer because it is a non-depolarizing neuromuscular blocking agent that undergoes **Hoffmann elimination**. This is a unique spontaneous molecular degradation process that occurs at physiological pH and temperature, independent of renal or hepatic function. * **Mechanism:** In Hoffmann elimination, the drug molecule breaks down into inactive metabolites (primarily **laudanosine** and monoquaternary acrylate). Because it does not rely on organ-based metabolism, Atracurium (and its isomer Cisatracurium) is the drug of choice for muscle relaxation in patients with **renal or hepatic failure**. **Analysis of Incorrect Options:** * **A. d-tubocurarine:** This is a prototype non-depolarizing blocker primarily eliminated by the kidneys (unaltered) and partly by the liver. It is known for causing significant histamine release. * **B. Acetylcholine:** This neurotransmitter is rapidly hydrolyzed by the enzyme **pseudocholinesterase** (butyrylcholinesterase) in the plasma and acetylcholinesterase at the synapse, not by spontaneous degradation. * **C. Acetazolamide:** This is a carbonic anhydrase inhibitor used as a diuretic and for glaucoma. It is excreted unchanged in the urine via active tubular secretion. **High-Yield Clinical Pearls for NEET-PG:** * **Cisatracurium:** An isomer of atracurium that also undergoes Hoffmann elimination but is more potent and produces less laudanosine, reducing the risk of seizures. * **Laudanosine Toxicity:** The major metabolite of atracurium, laudanosine, can cross the blood-brain barrier and may cause **CNS excitation or seizures** if it accumulates during prolonged infusions. * **Temperature/pH Sensitivity:** Since Hoffmann elimination is temperature and pH-dependent, the rate of drug degradation decreases in patients with **hypothermia or acidosis**, potentially prolonging the duration of neuromuscular blockade.

Q: Dose-response curves of salbutamol for bronchodilation and tachycardia are widely separated on the dose axis. This information suggests that salbutamol is:

A highly selective drug. ### Explanation **1. Why Option D is Correct: The Concept of Selectivity** Selectivity refers to the ability of a drug to act on a specific receptor or tissue at a lower dose than that required to produce effects at other sites. In this scenario, the **Dose-Response Curves (DRC)** for bronchodilation (mediated by $\beta_2$ receptors) and tachycardia (mediated by $\beta_1$ and $\beta_2$ receptors in the heart) are "widely separated." This indicates that a therapeutic effect (bronchodilation) is achieved at a much lower dose than the adverse effect (tachycardia). The greater the distance between these two curves on the dose axis, the higher the **selectivity** of the drug for the target tissue. **2. Why Other Options are Incorrect:** * **Option A (Potency):** Potency refers to the amount of drug needed to produce an effect. While Salbutamol is potent, the separation of curves describes *selectivity*, not how much drug is needed in absolute terms. * **Option B (Efficacy):** Efficacy is the maximum response ($E_{max}$) a drug can produce. The horizontal separation of curves relates to the dose (x-axis), not the maximum height of the response (y-axis). * **Option C (Toxicity):** A drug with widely separated curves for therapeutic and toxic effects is actually **safer**, as it possesses a high **Therapeutic Index**. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Selectivity is Dose-Dependent:** At higher doses, selectivity is lost. High doses of Salbutamol (e.g., via nebulization) will eventually cause $\beta_1$ stimulation, leading to tachycardia and tremors. * **Therapeutic Index (TI):** Calculated as $LD_{50} / ED_{50}$. A "widely separated" curve implies a wide TI, making the drug safer. * **Salbutamol vs. Isoprenaline:** Isoprenaline is a non-selective $\beta$-agonist; its curves for bronchodilation and tachycardia would be much closer together compared to Salbutamol.

Q: Variation in the sensitivity of response to increasing doses of a drug in different individuals can be obtained from which type of dose-response curve?

Quantal dose-response curve. **Explanation:** The core of this question lies in distinguishing between how an individual responds to a drug versus how a population responds. **1. Why Option B is Correct:** A **Quantal Dose-Response Curve (QDRC)** describes an "all-or-none" response (e.g., sleep/no sleep, death/survival) across a population. It plots the fraction of the population that manifests a specific effect at increasing doses. Because individuals have different genetic makeups and physiological states (**inter-individual variation**), they require different doses to achieve the same effect. The QDRC is the primary tool used to visualize this variation in sensitivity and to determine the **Therapeutic Index (TI)**. **2. Why Other Options are Incorrect:** * **A. Graded Dose-Response Curve:** This measures the intensity of a response in a **single individual** as the dose increases (e.g., the increase in heart rate with increasing doses of Adrenaline). It defines efficacy and potency but does not account for population-wide sensitivity variations. * **C. Potency:** This refers to the amount of drug (dose) required to produce an effect of a given intensity. It is determined by the $EC_{50}$ on a Graded curve. * **D. Efficacy:** This refers to the maximal response ($E_{max}$) a drug can produce, regardless of dose. **NEET-PG High-Yield Pearls:** * **Graded Curve:** Tells us about **Efficacy** (Maximal effect) and **Potency** ($EC_{50}$). * **Quantal Curve:** Tells us about **Selectivity**, **Safety**, and **Variability** ($ED_{50}$, $TD_{50}$, $LD_{50}$). * **Therapeutic Index (TI):** Calculated from the Quantal curve as $TI = LD_{50} / ED_{50}$. A higher TI indicates a safer drug. * **Standard Safety Margin:** Also derived from the Quantal curve: $[(LD_1 - ED_{99}) / ED_{99}] \times 100$.

Q: Acetylsalicylic acid and phenobarbitone are better absorbed from the stomach because they are:

Weak acids that remain non-ionic in gastric pH. ### Explanation **1. Why Option A is Correct: The pH Partition Hypothesis** Drug absorption across biological membranes occurs primarily via **passive diffusion**. For a drug to diffuse through the lipid bilayer of the stomach lining, it must be in its **lipid-soluble, non-ionized (uncharged) form**. According to the Henderson-Hasselbalch equation, **weak acids** (like Aspirin/Acetylsalicylic acid and Phenobarbitone) exist predominantly in their non-ionized form in an acidic environment (low pH). Since the gastric pH is highly acidic (~1–2), these drugs remain uncharged and are readily absorbed through the gastric mucosa. **2. Why the Other Options are Incorrect:** * **Option B:** If weak acids were ionic in the stomach, they would be water-soluble and lipid-insoluble, preventing them from crossing the lipid membrane. * **Option C:** Strong acids (like HCl) are almost completely ionized regardless of pH. High ionization prevents passive diffusion across membranes. * **Option D:** Weak bases (e.g., Atropine, Morphine) become **ionized** (protonated) in acidic environments. This "traps" them in the stomach, preventing absorption until they reach the more alkaline environment of the small intestine. **3. High-Yield Clinical Pearls for NEET-PG:** * **Ion Trapping:** This principle is used to treat toxicity. To accelerate the excretion of a **weak acid** (like Phenobarbitone or Salicylates), we **alkalinize the urine** with Sodium Bicarbonate. This ionizes the drug in the renal tubules, preventing reabsorption and "trapping" it in the urine for excretion. * **Site of Absorption:** Although weak acids are chemically favored for absorption in the stomach, the **small intestine** remains the major site of absorption for *most* drugs (including weak acids) due to its massive surface area (villi/microvilli). * **Pka:** When pH = pKa, 50% of the drug is ionized and 50% is non-ionized.

Q: Which of the following is an example of a Phase I xenobiotic reaction?

Hydroxylation. Drug metabolism (biotransformation) occurs in two distinct phases to convert lipophilic drugs into hydrophilic metabolites for excretion [1, 2]. **Phase I Reactions (Nonsynthetic)** These reactions involve the introduction or unmasking of a functional group (like –OH, –NH2, or –SH). The primary goal is to make the molecule more polar or prepare it for Phase II [2]. * **Hydroxylation** is a classic example of an **Oxidation** reaction, which is the most common Phase I process, typically mediated by the Cytochrome P450 (CYP450) enzyme system [2]. Other Phase I reactions include reduction and hydrolysis [1, 2]. **Explanation of Incorrect Options** Options A, C, and D are all **Phase II Reactions (Synthetic)**. These involve the **conjugation** of a drug or its Phase I metabolite with an endogenous substance to form a highly polar, inactive conjugate [2]. * **Acetylation (A):** Catalyzed by NAT enzymes (e.g., Isoniazid, Hydralazine) [1]. * **Methylation (C):** Transfer of a methyl group (e.g., Epinephrine, Dopamine). * **Glucuronidation (D):** The most common Phase II reaction, catalyzed by UGT enzymes (e.g., Morphine, Bilirubin) [2]. **High-Yield NEET-PG Pearls:** * **Mnemonic for Phase II:** "S-M-A-G" (Sulfation, Methylation, Acetylation, Glucuronidation). * **Exception:** Most Phase II metabolites are inactive [1], but **Morphine-6-glucuronide** is more potent than morphine itself. * **Microsomal vs. Non-microsomal:** Glucuronidation is the only Phase II reaction that occurs in the microsomes; all others are non-microsomal (cytosolic). * **Age Factor:** Neonates are deficient in glucuronidation, leading to **Gray Baby Syndrome** with Chloramphenicol.

Q: Which drug follows first-order kinetics for elimination?

All of the above. **Explanation:** The correct answer is **D. All of the above.** **Underlying Concept: First-Order vs. Zero-Order Kinetics** Most drugs follow **First-Order Kinetics**, where a constant *fraction* of the drug is eliminated per unit of time. The rate of elimination is directly proportional to the plasma concentration. In contrast, **Zero-Order Kinetics** occurs when a constant *amount* of drug is eliminated per unit of time because the elimination pathways (enzymes/transporters) are saturated. **Analysis of Options:** * **Opioids (e.g., Morphine):** These are metabolized primarily by the liver via glucuronidation. At therapeutic doses, the enzymes are not saturated, following first-order kinetics. * **Verapamil:** A calcium channel blocker that undergoes extensive first-pass metabolism. It follows first-order kinetics, meaning its half-life remains constant regardless of the dose. * **Lignocaine:** An amide local anesthetic and antiarrhythmic. It is cleared by the liver with a high extraction ratio, following first-order kinetics under normal physiological conditions. **High-Yield Clinical Pearls for NEET-PG:** To excel in NEET-PG, it is more efficient to memorize the exceptions—drugs that follow **Zero-Order Kinetics** (Non-linear kinetics)—using the mnemonic **"WATT P"**: * **W**arfarin * **A**lcohol (Ethanol) * **T**heophylline * **T**olbutamide * **P**henytoin / **P**ropanol (at high doses) / **P**yrazinamide / **P**alicylates (Aspirin) **Key Distinction:** For first-order drugs, the **Half-life ($t_{1/2}$)** is constant. For zero-order drugs, the half-life varies with the dose, increasing as the plasma concentration increases.

Q: Steady-state plasma concentration obtained after a dosage regimen depends on which of the following?

Dosing rate. **Explanation:** The **Steady-State Concentration ($C_{ss}$)** is the point during a drug dosage regimen where the rate of drug administration (input) equals the rate of drug elimination (output) [1]. **1. Why "Dosing Rate" is Correct:** The fundamental formula for steady-state concentration is: $C_{ss} = \frac{\text{Dosing Rate}}{\text{Clearance (CL)}}$ [1] The **Dosing Rate** is the amount of drug administered per unit of time (e.g., mg/hr). Since $C_{ss}$ is directly proportional to the dosing rate, any change in the rate of administration will directly alter the plateau concentration [3]. If you double the dosing rate, you double the $C_{ss}$. **2. Why the Other Options are Incorrect:** * **Duration of Action (A):** This is a clinical effect of the drug's pharmacodynamics and half-life, not a determinant of the plasma level achieved at steady state. * **Half-life ($t_{1/2}$) (C):** This is a common distractor. Half-life determines the **time taken** to reach steady state (usually 4–5 half-lives), but it does not determine the **level (concentration)** of the steady state itself [3]. * **Dosage Interval (D):** While the interval affects the "fluctuations" (peaks and troughs) between doses, the average $C_{ss}$ is determined by the total dosing rate (Dose/Interval) [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Time to Steady State:** It takes approximately **4 to 5 half-lives** to reach steady state, regardless of the dose or dosing interval [3]. * **Loading Dose:** Used to achieve therapeutic levels rapidly (bypassing the 4–5 half-lives wait), but it does not change the final $C_{ss}$ [2]. * **Maintenance Dose:** Calculated based on Clearance to maintain the $C_{ss}$ [1]. * **Key Formula:** $\text{Dosing Rate} = C_{ss} \times \text{Clearance}$.

Q: What is the most important factor governing the absorption of a drug from intact skin?

Lipid solubility of the drug. The absorption of drugs through intact skin (transdermal absorption) occurs primarily via passive diffusion through the stratum corneum, the outermost layer of the epidermis [1]. This layer acts as a lipid-rich, semi-permeable barrier. 1. Why Lipid Solubility is Correct: The stratum corneum is composed of keratinized cells embedded in a lipid matrix. For a drug to penetrate this barrier, it must be highly lipid-soluble. According to Fick’s Law of Diffusion, the rate of movement across a biological membrane is directly proportional to the lipid-water partition coefficient [1]. Therefore, lipid solubility is the primary determinant of how effectively a drug can cross the skin into the systemic circulation. 2. Analysis of Incorrect Options: * Molecular Weight (A): While smaller molecules cross more easily, lipid solubility is the more critical prerequisite. Even small molecules cannot cross if they are highly hydrophilic. * Site of Application (B): Skin thickness varies (e.g., thin on the scrotum/post-auricular area, thick on palms/soles), which affects the rate of absorption, but it is not the fundamental property of the drug governing the process. * Nature of the Base (D): The vehicle (ointment vs. cream) can enhance absorption by hydrating the stratum corneum or increasing drug contact time, but it remains secondary to the drug’s intrinsic lipid solubility. Clinical Pearls for NEET-PG: * Hydration: Absorption is significantly increased if the skin is well-hydrated (e.g., using occlusive dressings). * Organophosphates: These are highly lipid-soluble, explaining why systemic toxicity occurs rapidly after accidental skin contact. * Pro-drug approach: Highly polar drugs are often converted into lipid-soluble esters to improve topical penetration.

Question 1

Which of the following drugs undergoes Hoffmann elimination?

Accepted Answer

Atracurium

Answer

d-tubocurarine

Answer

Acetylcholine

Answer

Acetazolamide

Question 2

Dose-response curves of salbutamol for bronchodilation and tachycardia are widely separated on the dose axis. This information suggests that salbutamol is:

Accepted Answer

A highly selective drug

Answer

A highly potent cardiac stimulant

Answer

A highly efficacious bronchodilator

Answer

A highly toxic drug

Question 3

Loading dose depends on the following factors except:

Accepted Answer

Clearance of the drug

Answer

Drug concentration to be achieved

Answer

Volume of distribution

Answer

Bioavailability of drug

Question 4

Variation in the sensitivity of response to increasing doses of a drug in different individuals can be obtained from which type of dose-response curve?

Accepted Answer

Quantal dose-response curve

Answer

Graded dose-response curve

Answer

Potency

Answer

Efficacy

Question 5

Acetylsalicylic acid and phenobarbitone are better absorbed from the stomach because they are:

Accepted Answer

Weak acids that remain non-ionic in gastric pH

Answer

Weak acids that remain ionic in gastric pH

Answer

Strong acids that are fully ionized in gastric pH

Answer

Weak bases that are ionized at gastric pH

Question 6

Which of the following is an example of a Phase I xenobiotic reaction?

Accepted Answer

Hydroxylation

Answer

Acetylation

Answer

Methylation

Answer

Glucuronidation

Question 7

Which drug follows first-order kinetics for elimination?

Accepted Answer

All of the above

Answer

Opioids

Answer

Verapamil

Answer

Lignocaine

Question 8

Steady-state plasma concentration obtained after a dosage regimen depends on which of the following?

Accepted Answer

Dosing rate

Answer

Duration of action of the drug

Answer

Half-life of a drug

Answer

Dosage interval

Question 9

What is the most important factor governing the absorption of a drug from intact skin?

Accepted Answer

Lipid solubility of the drug

Answer

Molecular weight of the drug

Answer

Site of application

Answer

Nature of the base used in the formulation

Question 10

Which of the following drugs undergoes most of its metabolism presystemically?

Accepted Answer

Propranolol

Answer

Salbutamol

Answer

Verapamil

Answer

Paracetamol

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?